###begin article-title 0
Candidate Gene Association Study in Type 2 Diabetes Indicates a Role for Genes Involved in beta-Cell Function as Well as Insulin Action
###end article-title 0
###begin article-title 1
Large-Scale Association Study Confirms Genetic Complexity Underlying Type 2 Diabetes
###end article-title 1
###begin p 2
###xml 736 741 733 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
###xml 768 774 765 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 785 791 782 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC2A2</italic>
###xml 801 806 798 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 824 827 817 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INS</italic>
###xml 1113 1117 1106 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSR</italic>
###xml 1119 1125 1112 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3R1</italic>
###xml 1131 1135 1124 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOS1</italic>
Type 2 diabetes is an increasingly common, serious metabolic disorder with a substantial inherited component. It is characterised by defects in both insulin secretion and action. Progress in identification of specific genetic variants predisposing to the disease has been limited. To complement ongoing positional cloning efforts, we have undertaken a large-scale candidate gene association study. We examined 152 SNPs in 71 candidate genes for association with diabetes status and related phenotypes in 2,134 Caucasians in a case-control study and an independent quantitative trait (QT) cohort in the United Kingdom. Polymorphisms in five of 15 genes (33%) encoding molecules known to primarily influence pancreatic beta-cell function-ABCC8 (sulphonylurea receptor), KCNJ11 (KIR6.2), SLC2A2 (GLUT2), HNF4A (HNF4alpha), and INS (insulin)-significantly altered disease risk, and in three genes, the risk allele, haplotype, or both had a biologically consistent effect on a relevant physiological trait in the QT study. We examined 35 genes predicted to have their major influence on insulin action, and three (9%)-INSR, PIK3R1, and SOS1-showed significant associations with diabetes. These results confirm the genetic complexity of Type 2 diabetes and provide evidence that common variants in genes influencing pancreatic beta-cell function may make a significant contribution to the inherited component of this disease. This study additionally demonstrates that the systematic examination of panels of biological candidate genes in large, well-characterised populations can be an effective complement to positional cloning approaches. The absence of large single-gene effects and the detection of multiple small effects accentuate the need for the study of larger populations in order to reliably identify the size of effect we now expect for complex diseases.
###end p 2
###begin p 3
The absence of large single gene effects and the detection of multiple small effects confirms the genetic complexity of type 2 diabetes and the need for even larger studies
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 361 377 361 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-King1">King et al. 1998</xref>
###xml 533 550 533 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Weyer1">Weyer et al. 1999</xref>
###xml 878 889 878 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Zimmet1">Zimmet 1982</xref>
###xml 993 1012 993 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Vionnet1">Vionnet et al. 1992</xref>
###xml 1014 1035 1014 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Yamagata1">Yamagata et al. 1996a</xref>
###xml 1037 1042 1037 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Yamagata2">1996b</xref>
###xml 1044 1064 1044 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Horikawa1">Horikawa et al. 1997</xref>
###xml 1066 1086 1066 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Stoffers1">Stoffers et al. 1997</xref>
###xml 1088 1107 1088 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Barroso1">Barroso et al. 1999</xref>
###xml 1109 1128 1109 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Malecki2">Malecki et al. 1999</xref>
###xml 1130 1148 1130 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Savage1">Savage et al. 2002</xref>
###xml 1640 1646 1640 1646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 1729 1749 1729 1749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Horikawa2">Horikawa et al. 2000</xref>
###xml 1812 1818 1812 1818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 1980 1997 1980 1997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Baier2">Baier et al. 2000</xref>
###xml 1999 2007 1999 2007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Cox1">Cox 2001</xref>
###xml 2009 2026 2009 2026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Evans1">Evans et al. 2001</xref>
###xml 2028 2046 2028 2046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Hegele2">Hegele et al. 2001</xref>
###xml 2048 2064 2048 2064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Tsai1">Tsai et al. 2001</xref>
###xml 2066 2084 2066 2084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Daimon1">Daimon et al. 2002</xref>
###xml 2086 2104 2086 2104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Elbein1">Elbein et al. 2002</xref>
###xml 2106 2124 2106 2124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Garant1">Garant et al. 2002</xref>
Type 2 diabetes is a serious metabolic disease associated with an increased risk of premature death and substantial disability, largely mediated through its adverse effects on the vasculature. The prevalence of the disease is increasing, and the World Health Organisation estimates suggest that by 2025 there will be 300 million affected individuals worldwide (King et al. 1998). The disorder is characterised by a combination of impaired insulin secretion and insulin action, both of which precede and predict the onset of disease (Weyer et al. 1999). Through its adverse impact on insulin action, obesity is a major risk factor for the disease. Although environmental factors, both post- and prenatal, play an important role in determining the risk of disease, a substantial body of evidence supports the notion that disease susceptibility is influenced by inherited factors (Zimmet 1982). While the molecular basis for several uncommon Mendelian forms of Type 2 diabetes have been defined (Vionnet et al. 1992; Yamagata et al. 1996a, 1996b; Horikawa et al. 1997; Stoffers et al. 1997; Barroso et al. 1999; Malecki et al. 1999; Savage et al. 2002), the nature and range of allelic variants conferring susceptibility to the more common forms of this disorder remain poorly defined. Many investigators have embarked on attempts to identify diabetes susceptibility genes through genome-wide linkage-based approaches using multigenerational pedigrees and/or large numbers of affected sibpairs. Regions of significant linkage, some of which have been replicated in more than one study, have been identified. To date, however, only Calpain 10 (CAPN10; LocusLink ID 11132) has emerged from such studies as a new putative diabetogene (Horikawa et al. 2000). While some subsequent studies have supported a role for the CAPN10 alleles originally described as susceptibility alleles, others have found associations with different alleles and some have found no association with this gene (Baier et al. 2000; Cox 2001; Evans et al. 2001; Hegele et al. 2001; Tsai et al. 2001; Daimon et al. 2002; Elbein et al. 2002; Garant et al. 2002).
###end p 5
###begin p 6
###xml 530 535 526 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 631 652 627 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Altshuler1">Altshuler et al. 2000</xref>
###xml 737 743 733 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 799 815 795 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Hani1">Hani et al. 1998</xref>
###xml 817 834 813 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Gloyn1">Gloyn et al. 2001</xref>
###xml 836 840 832 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Gloyn2">2003</xref>
###xml 842 866 838 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Love-Gregory1">Love-Gregory et al. 2003</xref>
###xml 868 887 864 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Nielsen1">Nielsen et al. 2003</xref>
The positional cloning effort has been supplemented by a large number of studies examining specific candidate genes using a variety of methodologies, mostly of the case-control association design. Although many positive reports have emerged, few have been consistently replicated. Of these candidates, the most compelling evidence to date, generated from a meta-analysis of multiple published studies, is that a common amino acid variant in the N-terminus of the nuclear receptor peroxisome proliferator-activated receptor gamma (PPARG; LocusLink ID 5468) confers significant protection against the development of Type 2 diabetes (Altshuler et al. 2000). More recently, evidence has accumulated supporting a role for the E23K variant of KCNJ11 (LocusLink ID 3767) in Type 2 diabetes predisposition (Hani et al. 1998; Gloyn et al. 2001, 2003; Love-Gregory et al. 2003; Nielsen et al. 2003).
###end p 6
###begin p 7
Whole-genome association studies in large case-control populations may ultimately have the greatest power to detect alleles of small but significant effects on the susceptibility to common diseases such as Type 2 diabetes. As yet, however, the resource implications of such an approach are prohibitive. In the meantime, knowledge of both mammalian biology and disease pathogenesis is progressing rapidly, and it is possible to identify a large panel of known genes, the dysfunction of which might reasonably be considered likely to contribute to Type 2 diabetes. In this study we have identified 152 informative single nucleotide polymorphisms (SNPs) in 71 such genes and, using these, have examined their association with Type 2 diabetes and related intermediate phenotypes in Caucasian subjects from the United Kingdom.
###end p 7
###begin title 8
Results/Discussion
###end title 8
###begin title 9
Overall Study Design
###end title 9
###begin p 10
###xml 730 751 730 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Altshuler1">Altshuler et al. 2000</xref>
Candidate gene studies are based on selection of genes with a known or inferred biological function whose role makes it plausible that they may predispose to disease or the observed phenotype. These types of studies are similar to traditional epidemiological approaches in which an a priori hypothesis between exposure to a given factor (in this case, a genotype at a given locus) and disease is formulated. To date, most Type 2 diabetes candidate gene studies have largely lacked thoroughness and sensitivity, as they have tested a limited number of genes and variants in small populations or in populations that were poorly matched or phenotyped, frequently resulting in a lack of replication of the weak associations detected (Altshuler et al. 2000). Our strategy aimed to address these problems by a unique combination of features, including comprehensive SNP discovery in a large number of candidate genes, testing of a large number of SNPs, use of two independent populations, and analysis of haplotypes in addition to individual SNPs where possible.
###end p 10
###begin p 11
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0000020-g001">Figure 1</xref>
###xml 166 173 166 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t101">Table 1</xref>
###xml 1128 1136 1125 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="st001">Table S1</xref>
###xml 766 771 <span type="species:ncbi:9606">human</span>
Figure 1 illustrates the overall design of the study. On the basis of their known or putative role in glucose metabolism, 71 candidate genes were selected for study (Table 1). These were subdivided into three broad groups: (1) genes primarily involved in pancreatic beta-cell function; (2) genes primarily influencing insulin action and glucose metabolism in the main target tissues, muscle, liver, and fat; and (3) other genes. This group includes genes that influence processes potentially relevant to diabetes, such as energy intake, energy expenditure, and lipid metabolism. A de novo search for common SNPs was undertaken using fluorescent single-stranded conformation polymorphism (fSSCP) examination of all coding regions and splice junctions in a variety of human populations. All genes were minimally screened against 47 samples of mixed ethnicity, providing 0.99 probability of detecting variants with a minor allele frequency of 0.05. Our 'in-house' polymorphism detection programme identified 954 SNPs in the 71 genes, with a range of allele frequencies from 0.003 to 0.50. Of the 152 SNPs chosen for further study (Table S1), the great majority had a minor allele frequency of greater than 5%, but in a few instances less frequent variants were typed when the candidate gene had strong biological plausibility and there were no known polymorphisms of higher frequency at the time of SNP selection.
###end p 11
###begin p 12
###xml 1392 1392 1389 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
The 152 SNPs were genotyped in a population-based cohort of 517 unrelated Caucasians in the United Kingdom with Type 2 diabetes and an equal number of controls with normal glycated haemoglobin (HbA1c) levels, individually matched to cases by age, sex, and geographical location. A second independent population was also genotyped for the same 152 SNPs. This consisted of 1,100 middle-aged Caucasian subjects in the United Kingdom who had been extensively and serially phenotyped for glucose tolerance and variables related to insulin secretion, insulin action, and adiposity. In the first stage of data analysis, all SNPs (and haplotypes when multiple SNPs were present at the same gene) were examined for their association with diabetes in the case-control study using multiple models of inheritance. In the second phase of analysis, all SNPs and haplotypes showing statistically significant association with diabetes status in the first phase were examined for association with glucose levels and other intermediate phenotypes in the quantitative trait (QT) study population. The intermediate phenotypes chosen for study were fasting and 2-h post-glucose load plasma glucose levels (measures of glucose tolerance), fasting insulin (a measure of insulin sensitivity), 30-min insulin incremental response (a measure of beta-cell function), and body mass index (BMI) (a measure of adiposity).
###end p 12
###begin p 13
###xml 752 760 748 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0000020-g002">Figure 2</xref>
Power to detect an association is dependent on several factors: the frequency of the 'predisposing' allele, genotype, or haplotype; the accepted false-positive or Type 1 error rate (alpha); and the odds ratio (OR) or effect size. Rarer alleles, genotypes, or haplotypes with small effects require larger sample sizes to attain the same power to detect an association, as compared to more frequent alleles or alleles with larger effects. At the time that we collected the populations and designed this study, our power calculations had shown that a sample size of 500 cases and 500 matched controls would have 80% power to detected effect sizes as small as 1.3-1.7 OR, depending on the frequency of the predisposing allele, with a 5% Type 1 error rate (Figure 2).
###end p 13
###begin title 14
Overview of Results of Association Studies
###end title 14
###begin p 15
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="st001">Table S1</xref>
###xml 391 393 391 393 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">. </bold>
###xml 493 494 493 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 529 536 529 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t002">Table 2</xref>
###xml 612 616 612 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOS1</italic>
###xml 638 644 638 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC2A2</italic>
###xml 666 674 666 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3R1 (</italic>
###xml 694 699 694 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
###xml 704 710 704 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 736 740 736 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSR</italic>
###xml 761 761 761 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 808 813 808 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 834 838 834 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSR</italic>
###xml 844 849 844 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
###xml 850 856 850 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 934 942 934 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0000020-g003">Figure 3</xref>
###xml 944 951 944 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t003">Table 3</xref>
###xml 972 977 972 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 1129 1137 1129 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="st002">Table S2</xref>
###xml 1306 1313 1306 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t003">Table 3</xref>
###xml 1378 1383 1378 1383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
###xml 1384 1390 1384 1390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 1392 1397 1392 1397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 1403 1407 1403 1407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSR</italic>
Table S1 shows the genotype counts for all 152 SNPs in the case-control and QT studies. In the control subjects, 16 SNPs (10.6%) had a minor allele frequency below 5%; 19 (12.5%) had a minor allele frequency between 5% and 10%; and 117 (76.9%) had a minor allele frequency greater than or equal to 10%. Each variant was tested for association with disease status under several genetic models. Twenty SNPs in 11 different genes showed statistically significant association with disease status (p < 0.05) under at least one model (Table 2). The strongest statistical evidence for disease association was for genes SOS1 (LocusLink ID 6654), SLC2A2 (LocusLink ID 6514), PIK3R1 (LocusLink ID 5295), ABCC8 and KCNJ11 (LocusLink ID 6833), and INSR (LocusLink ID 3643). Of the 29 loci with multiple SNPs, only three-HNF4A (LocusLink ID 3172) INSR, and ABCC8-KCNJ11-showed significant association of particular haplotypes with disease status (Figure 3; Table 3). In only one case (HNF4A) was a haplotype significantly associated with disease risk (see below) when no significant association was seen with any individual SNP in that gene. Table S2, shows the results of association studies undertaken in the QT population, further examining the SNPs that had shown significant association in the case-control study. Table 3 shows the relationship between disease-associated haplotypes at ABCC8-KCNJ11, HNF4A, and INSR with intermediate phenotypes in the QT study. We now consider in more detail, the data for those genes where the strongest and most consistent effects were seen.
###end p 15
###begin title 16
Genes Primarily Affecting beta-Cell Function
###end title 16
###begin title 17
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
###xml 10 16 10 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
ABCC8 and KCNJ11 (encoding, respectively, the sulphonylurea receptor and inwardly rectifying potassium channel KIR 6.2).
###end title 17
###begin p 18
###xml 173 179 170 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 219 224 216 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
###xml 465 471 462 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 618 619 615 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 670 677 667 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t002">Table 2</xref>
###xml 683 688 680 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
###xml 881 882 878 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 897 904 894 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t002">Table 2</xref>
###xml 946 947 943 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 962 969 959 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t002">Table 2</xref>
###xml 1119 1127 1116 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="st002">Table S2</xref>
###xml 1152 1157 1149 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
###xml 1214 1215 1211 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1230 1237 1227 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t002">Table 2</xref>
###xml 1289 1290 1286 1287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1368 1369 1365 1366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1422 1423 1419 1420 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1472 1473 1469 1470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1730 1731 1727 1728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1783 1791 1780 1788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="st002">Table S2</xref>
###xml 1886 1887 1883 1884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1902 1909 1899 1906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t002">Table 2</xref>
###xml 2175 2176 2172 2173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 2190 2198 2187 2195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="st002">Table S2</xref>
###xml 2298 2303 2295 2300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
###xml 2308 2314 2305 2311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 2438 2446 2435 2443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0000020-g003">Figure 3</xref>
###xml 2619 2626 2616 2623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t003">Table 3</xref>
The genes encoding the two molecular components of the voltage-gated potassium channel of the pancreatic beta-cell are located within 4.5 kb of each other on Chromosome 11. KCNJ11 encodes the channel protein KIR6.2 and ABCC8 encodes an ATP-binding cassette (ABC) transporter-containing transmembrane protein (SUR1) that is thought to regulate the activity of the channel and that also contains the site to which sulphonylurea antidiabetic drugs bind. Three SNPs in KCNJ11 were associated with disease under multiple genetic models. The strongest statistical association in this gene was with a 3'-SNP (SNP74; OR 0.59, p = 0.0027 under recessive model for allele 2) (see Table 2). In ABCC8, five SNPs were associated with disease status under multiple models; the strongest evidence for association with disease were with SNP79 and SNP81, respectively an intronic variant (OR 1.68, p = 0.0043; see Table 2) and a missense variant A1369S (OR 1.68, p = 0.0048; see Table 2). Although neither of these two SNPs was significantly associated with any trait in the QT study, two other SNPs showed effects in the QT study (see Table S2). SNP84 (IVS18-36) from ABCC8, which associated with increased disease risk (OR 3.43, p = 0.0163; see Table 2) also associated with increased BMI (mean 28.2 kg/m2, 95% confidence interval [CI] [26.6, 29.9] for homozygous 22 versus 26.2 kg/m2, 95% CI [25.9, 26.5] for homozygous 11 and 26.3 kg/m2, 95% CI [25.7, 26.8] for heterozygous subjects; p = 0.016) and associated with borderline significance with higher fasting glucose (5.53 mmol/l, 95% CI [5.29, 5.77] for homozygous 22 versus 5.30 mmol/l, 95% CI [5.26, 5.35] for homozygous 11 and 5.27 mmol/l, 95% CI [5. 19, 5.35] for heterozygous subjects; p = 0.057) under a recessive model for allele 2 (see Table S2). SNP87 (K649), which was also significantly associated with increased disease risk (OR 3.90, p = 0.0157; see Table 2), also showed borderline significant association with decreased insulin secretion (23.6 pmol/mmol, 95% CI [18.6, 30.1] for homozygous 22 versus 29.8 pmol/mmol, 95% CI [28.4, 31.1] for homozygous 11 and 30.9 pmol/mmol, 95% CI [28.6, 33.4] for heterozygous subjects; p = 0.054; see Table S2), consistent with a role for this gene in insulin secretion. Given the close physical proximity of ABCC8 and KCNJ11 and their role in the same functional unit, we performed haplotype reconstructions with data from both genes combined (see Figure 3A). Haplotype B was associated with increased disease risk (OR 1.46, 95% CI [1.14, 1.85]; data not shown), but did not show any significant association in the QT study (see Table 3).
###end p 18
###begin p 19
###xml 288 294 288 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 543 559 543 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Hani1">Hani et al. 1998</xref>
###xml 561 578 561 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Gloyn1">Gloyn et al. 2001</xref>
###xml 580 584 580 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Gloyn2">2003</xref>
###xml 586 622 586 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Schwanstecher1">Schwanstecher and Schwanstecher 2002</xref>
###xml 624 648 624 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Love-Gregory1">Love-Gregory et al. 2003</xref>
###xml 650 669 650 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Nielsen1">Nielsen et al. 2003</xref>
###xml 708 714 708 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 894 901 894 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t002">Table 2</xref>
###xml 1026 1027 1026 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1042 1049 1042 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t002">Table 2</xref>
###xml 1131 1151 1131 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Nielsen1">Nielsen et al. (2003</xref>
###xml 1177 1183 1177 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 1494 1519 1494 1519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Schwanstecher2">Schwanstecher et al. 2002</xref>
###xml 1875 1882 1875 1882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t004">Table 4</xref>
Mutations in each of these genes have been associated with familial persistent hyperinsulinaemia hypoglycaemia of infancy (PHHI), a rare disorder of glucose homeostasis characterised by up-regulated insulin secretion despite severe hypoglycaemia. In addition, evidence for association of KCNJ11 DNA variants with Type 2 diabetes has been evaluated in multiple studies, and until recently these data have been conflicting. Several recent studies have, however, suggested a role for the aminoacid variant E23K in Type 2 diabetes susceptibility (Hani et al. 1998; Gloyn et al. 2001, 2003; Schwanstecher and Schwanstecher 2002; Love-Gregory et al. 2003; Nielsen et al. 2003). In total we tested four SNPs at the KCNJ11 locus for association with disease status; of these, three were tightly linked (data not shown) and all three had a statistically significant association with disease status (see Table 2). In our study we replicated the effect of the E23K polymorphism in Type 2 diabetes predisposition (KK homozygous, OR 1.49, p = 0.0333; see Table 2) with an OR estimate in agreement with that demonstrated by the meta-analysis of Nielsen et al. (2003); in addition, two other KCNJ11 SNPs associated with disease risk (SNP74 and SNP76). The recent evidence from multiple studies and from meta-analysis for association of the E23K SNP with Type 2 diabetes, along with in vitro studies using cell lines expressing the E23K mutation showing an increased stimulation threshold of insulinsecretion (Schwanstecher et al. 2002), suggests that E23K is the functional variant leading to increased disease risk. Given our finding of high levels of linkage disequilibrium (LD) between SNP74 and SNP76 with E23K (data not shown), we adjusted the measures of association at these sites for the E23K genotype. These data suggest that these SNPs are independently associated with diabetes (Table 4).
###end p 19
###begin p 20
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
###xml 78 95 78 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Inoue1">Inoue et al. 1996</xref>
###xml 97 118 97 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Hansen5">T. Hansen et al. 1998</xref>
###xml 120 137 120 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Hart3">Hart et al. 1999b</xref>
###xml 234 255 234 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Altshuler1">Altshuler et al. 2000</xref>
###xml 340 345 340 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
###xml 392 397 392 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
###xml 420 426 420 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 484 489 484 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
###xml 545 550 545 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
###xml 580 586 580 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 619 624 619 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
###xml 698 699 698 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 713 714 713 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 753 760 753 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t002">Table 2</xref>
###xml 837 838 837 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 852 853 852 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 892 899 892 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t004">Table 4</xref>
###xml 1055 1056 1055 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1067 1068 1067 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1083 1084 1083 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1123 1130 1123 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t004">Table 4</xref>
###xml 1258 1263 1258 1263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
###xml 1305 1311 1305 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 1504 1525 1504 1525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Hansen6">T. Hansen et al. 2001</xref>
###xml 1556 1561 1556 1561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
ABCC8 variants have been associated with Type 2 diabetes in multiple studies (Inoue et al. 1996; T. Hansen et al. 1998; Hart et al. 1999b). However, a recent large study failed to replicate previous associations with Type 2 diabetes (Altshuler et al. 2000). In our study we found evidence for association with Type 2 diabetes in five of 16 ABCC8 SNPs tested. Owing to the physical mapping of ABCC8 in close proximity to KCNJ11, we further investigated whether the associations at the ABCC8 locus could be completely explained through LD between ABCC8 SNPs and the E23K variant at KCNJ11. After adjustment for E23K, two ABCC8 SNPs (SNP79 and SNP81) that were significantly associated with diabetes (p = 0.0043 and p = 0.0048 for the recessive model; see Table 2) prior to adjustment were no longer significantly associated with diabetes (p = 0.0536 and p = 0.1339 for the recessive model; see Table 4). However, for the remaining three SNPs (SNP84, SNP87, and SNP89), although the significance levels were reduced, they remained statistically significant (p = 0.0401, p = 0.0214, and p = 0.0445 for the recessive model; see Table 4). Moreover, the OR for two of these SNPs increased to 4.36 and 3.16, respectively. This suggests that there are effects at the ABCC8 locus that are independent from the E23K KCNJ11 variant. The lowered significance levels are likely due to loss of power resulting from the adjustment. Our data and that from at least nine other independent association and linkage studies (T. Hansen et al. 2001) have shown some evidence for ABCC8 involvement in Type 2 diabetes and related phenotypes.
###end p 20
###begin title 21
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC2A2</italic>
SLC2A2 (encoding GLUT2).
###end title 21
###begin p 22
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC2A2</italic>
###xml 184 190 181 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC2A2</italic>
###xml 232 232 229 229 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 324 331 321 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t002">Table 2</xref>
###xml 414 415 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1013 1013 1010 1010 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
SLC2A2 encodes the glucose transporter GLUT2, a member of the facilitative glucose transporter family that is highly expressed in pancreatic beta-cells and liver. We typed six SNPs in SLC2A2, three of which (SNP21, SNP23, and SNP24)were significantly associated with diabetes status with an OR of approximately 1.4-1.5 (see Table 2). The most highly significant association was with a T110I substitution (OR 1.49, p = 0.0059) under a dominant model for the minor allele. In the reduction process prior to haplotype estimations (see Materials and Methods), only one SNP (SNP21) contributed significantly to disease association. Therefore, haplotype reconstructions were not performed. In the QT study, all three disease-associated SNPs were also associated with lower levels of fasting plasma insulin. Rather surprisingly allele 2 (A) at T198, which was associated with increased disease risk, was associated with lower 2-h plasma glucose. No other significant associations with intermediate phenotypes were seen.
###end p 22
###begin p 23
###xml 82 88 82 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC2A2</italic>
###xml 263 277 263 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Li1">Li et al. 1991</xref>
###xml 279 297 279 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Baroni1">Baroni et al. 1992</xref>
###xml 299 319 299 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Tanizawa1">Tanizawa et al. 1994</xref>
###xml 321 339 321 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Moller2">Moller et al. 2001</xref>
###xml 342 348 342 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC2A2</italic>
###xml 424 425 424 425 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 1244 1249 1241 1246 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower</bold>
###xml 1381 1387 <span type="species:ncbi:9606">humans</span>
Multiple previous studies have sought evidence for association or linkage between SLC2A2 variants and Type 2 diabetes, and most have reported negative results. However, all studies have been small and were insufficiently powered to detect effects of modest size (Li et al. 1991; Baroni et al. 1992; Tanizawa et al. 1994; Moller et al. 2001). SLC2A2 is a highly plausible candidate gene for Type 2 diabetes, as it is a high Km transporter that regulates entry of glucose into the pancreatic beta-cell, thus initiating the cascade of events leading to insulin secretion. GLUT2 is also highly expressed in the liver, where it is involved in the regulation of both glucose uptake and output. It is notable that the alleles that associated with increased diabetes risk were also all associated with lower fasting insulin levels, suggesting that these may influence basal insulin secretion. However, interpretation is complex, as (1) fasting insulin is strongly influenced by insulin sensitivity and (2) the potential risk alleles were not associated with any impairment of insulin secretion in response to a glucose load. Finally, allele 2 (A) at T198, which associated with increased risk of diabetes in the case-control study, was associated with lower 2-h glucose in the QT study. Clearly, more detailed genetic mapping combined with functional studies (which will be challenging in humans owing to the inaccessibility of the pancreatic beta-cell) will be needed to identify the mechanism whereby variants in this gene influence diabetes risk.
###end p 23
###begin title 24
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
HNF4A (encoding hepatic nucleotide factor 4alpha).
###end title 24
###begin p 25
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MODY1</italic>
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF1</italic>
###xml 132 136 128 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF2</italic>
###xml 181 186 174 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FOXA2</italic>
###xml 604 622 588 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Fajans1">Fajans et al. 2001</xref>
###xml 652 657 636 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 750 758 734 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0000020-g003">Figure 3</xref>
###xml 919 919 903 903 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 1287 1294 1271 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t003">Table 3</xref>
###xml 1297 1302 1281 1286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 1326 1353 1310 1337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Argyrokastritis1">Argyrokastritis et al. 1997</xref>
###xml 1428 1446 1412 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Bowden1">Bowden et al. 1997</xref>
###xml 1448 1462 1432 1446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Ji1">Ji et al. 1997</xref>
###xml 1464 1482 1448 1466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Zouali1">Zouali et al. 1997</xref>
###xml 1484 1501 1468 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Ghosh1">Ghosh et al. 1999</xref>
###xml 1503 1520 1487 1504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Klupa1">Klupa et al. 2000</xref>
###xml 1522 1541 1506 1525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Permutt1">Permutt et al. 2001</xref>
###xml 1729 1734 1713 1718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 1938 1956 1922 1940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Moller1">Moller et al. 1997</xref>
###xml 1958 1977 1942 1961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Malecki1">Malecki et al. 1998</xref>
###xml 1979 1996 1963 1980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Ghosh1">Ghosh et al. 1999</xref>
###xml 1998 2015 1982 1999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Price1">Price et al. 2000</xref>
###xml 2238 2243 2222 2227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 2667 2690 2637 2660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Stoffel1">Stoffel and Duncan 1997</xref>
###xml 2692 2708 2662 2678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Shih1">Shih et al. 2000</xref>
HNF4A (the MODY1 gene) encodes an orphan hormone nuclear receptor that, together with TCF1 (LocusLink ID 6927), encoding HNF1alpha, TCF2 (LocusLink ID 6928), encoding HNF1beta, and FOXA2 (LocusLink ID 3170), encoding HNF3beta, constitutes part of a network of transcription factors controlling gene expression in pancreatic beta-cells, liver, and other tissues. In beta-cells, these transcription factors regulate expression of the insulin gene as well as genes encoding proteins involved in glucose transport and metabolism and in mitochondrial metabolism, all of which are linked to insulin secretion (Fajans et al. 2001). While no individual SNP in HNF4A was significantly associated with disease status, we identified a haplotype (haplotype B in Figure 3B) that was significantly associated with reduced disease risk (OR 0.83, 95% CI [0.68, 1.00]; data not shown). In the QT study, this 'reduced-risk' haplotype wassignificantly associated with increased insulin secretion (mean = 31.5 pmol/mmol, 95% CI [29.9, 33.3] versus 29.3 pmol/mmol, 95% CI [28.0, 30.6] for haplotype A and 30.9 pmol/mmol, 95% CI [28.1, 34.0] for haplotype C]. Carriers of this haplotype also showed a trend towards lower fasting and 2-h plasma glucose, compared to the subjects with the other haplotypes (see Table 3). HNF4A maps to Chromosome 20 (Argyrokastritis et al. 1997) in a region that has been linked to Type 2 diabetes in multiple studies (Bowden et al. 1997; Ji et al. 1997; Zouali et al. 1997; Ghosh et al. 1999; Klupa et al. 2000; Permutt et al. 2001). This positional information, combined with the known role of major mutations at this gene in the causation of autosomal-dominant maturity-onset diabetes of the young (MODY), has led to HNF4A being considered as a strong candidate for involvement in Type 2 diabetes. However, most studies to date have failed to identify an association between variants at this locus and disease susceptibility (Moller et al. 1997; Malecki et al. 1998; Ghosh et al. 1999; Price et al. 2000). This study differs from all other previous reports in its examination of haplotypes, as well as in the fact that it included several SNPs not previously examined. Our findings lead us to speculate as to how a particular HNF4A haplotype might be associated with lower risk of diabetes and increased insulin secretory capacity. The fact that a multiplicity of heterozygous nonsense and missense mutations in HNF4alpha lead to an insulinopaenic form of MODY strongly suggests that beta-cell dysfunction is sensitive to the amount of HNF4alpha in the beta-cell and that haploinsufficiency is the likely mode of molecular pathogenesis in that condition (Stoffel and Duncan 1997; Shih et al. 2000). It is plausible, therefore, that variants in this gene that enhance expression levels of the protein might lead to increased insulin secretory capacity and protection against diabetes.
###end p 25
###begin title 26
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INS</italic>
INS (encoding insulin).
###end title 26
###begin p 27
###xml 3 3 3 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 3 6 3 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INS</italic>
###xml 351 351 351 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 369 370 369 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 386 393 386 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t002">Table 2</xref>
###xml 536 539 536 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INS</italic>
###xml 665 685 665 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Huxtable1">Huxtable et al. 2000</xref>
###xml 751 754 751 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INS</italic>
TheINS (LocusLink ID 3630) gene encodes the hormone preproinsulin, which upon proteolytic cleavage generates mature insulin and C-peptide. We tested for association of a single SNP in the 3'-UTR (SNP72) of the insulin gene with disease status. This SNP was significantly associated with increased Type 2 diabetes risk under a recessive model for the T allele (OR 2.02, p = 0.0258) (see Table 2). In the QT study this SNP did not associate with any of the intermediate phenotypes studied. The insulin gene variable number tandem repeat (INS-VNTR) has been extensively studied and is proposed to exert pleiotropic effects on birth weight and diabetes susceptibility (Huxtable et al. 2000). However, evidence for this has been conflicting and a role for INS in Type 2 diabetes predisposition has not been definitively established. The data for the single SNP we tested suggest that either the insulin gene or other loci in LD may be involved in Type 2 diabetes risk.
###end p 27
###begin title 28
Genes Primarily Affecting Insulin Action
###end title 28
###begin title 29
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSR</italic>
INSR (encoding the insulin receptor).
###end title 29
###begin p 30
###xml 7 11 7 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSR</italic>
###xml 162 163 162 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 215 222 215 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t002">Table 2</xref>
###xml 357 365 357 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="st002">Table S2</xref>
###xml 385 393 385 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0000020-g003">Figure 3</xref>
###xml 400 404 400 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSR</italic>
###xml 1103 1110 1103 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t003">Table 3</xref>
###xml 1124 1128 1124 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSR</italic>
###xml 1632 1648 1632 1648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Hart1">Hart et al. 1996</xref>
###xml 1650 1655 1650 1655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Hart3">1999b</xref>
###xml 1700 1721 1700 1721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-OaRahilly1">O'Rahilly et al. 1991</xref>
###xml 1723 1727 1723 1727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-OaRahilly2">1992</xref>
###xml 1729 1750 1729 1750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Hansen4">L. Hansen et al. 1997</xref>
###xml 1813 1817 1813 1817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSR</italic>
At the INSR locus of the seven SNPs genotyped, we detected a single intronic SNP (SNP131) that was significantly associated with increased disease risk (OR 1.48, p = 0.0039 for the dominant model for allele 2) (see Table 2). In the QT study, this SNP also had a nonsignificant association with increased 2-h glucose under a dominant model for allele 2 (see Table S2). Haplotype C (see Figure 3C) for INSR was associated with increased disease risk (1.34 mmol/l, 95% CI [1.05, 1.71]; data not shown); in the QT study, there was a nonsignificant trend for subjects carrying this haplotype to have increased values for fasting glucose (5.32 mmol/l, 95% CI [5.24, 5.39] versus 5.27 mmol/l, 95% CI [5.21,5.33] for haplotype B and 5.27 mmol/l, 95% CI [5.23, 5.32] for haplotype A), 2-h glucose (6.00 mmol/l, 95% CI [5.80, 6. 20] versus 5.78 mmol/l, 95% CI [5.61, 5.96] for haplotype B and 5.87 mmol/l, 95% CI [5.75, 5.99] for haplotype A), and fasting insulin (41.8 pmol/l, 95% CI [39.2, 44.5] versus 40.4 pmol/l, 95% CI [38.4, 42.5] for haplotype B and 41.3 pmol/l, 95% CI [39.6, 43.1] for haplotype A) (see Table 3). A role for INSR in Type 2 diabetes and related phenotypes has long been sought. Many studies initiated over the past decade have explored the possibility that DNA variants at this locus would not only cause rare syndromes of extreme insulin resistance, but would also associate with increased Type 2 diabetes risk. In particular, the role of the Val985Met in disease predisposition has been analysed in many different populations, but the data remain inconclusive, with some studies suggesting a role for this variant (Hart et al. 1996, 1999b), while others do not support this finding (O'Rahilly et al. 1991, 1992; L. Hansen et al. 1997). In this study we provide preliminary evidence for a role of INSR in diabetes susceptibility through genotyping of a previously untested SNP in case-control studies and via haplotype analysis using multiple SNPs in the gene.
###end p 30
###begin title 31
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3R1</italic>
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOS1</italic>
PIK3R1 and SOS1.
###end title 31
###begin p 32
###xml 9 16 9 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3R1,</italic>
###xml 334 335 330 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 383 384 379 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 422 429 418 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t002">Table 2</xref>
###xml 644 652 640 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="st002">Table S2</xref>
###xml 1077 1098 1073 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Hansen4">T. Hansen et al. 1997</xref>
###xml 1100 1104 1096 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Hansen2">2001</xref>
###xml 1106 1127 1102 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Kawanishi1">Kawanishi et al. 1997</xref>
###xml 1229 1246 1225 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Baier1">Baier et al. 1998</xref>
###xml 1384 1402 1380 1398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Baynes1">Baynes et al. 2000</xref>
###xml 1404 1422 1400 1418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Almind1">Almind et al. 2002</xref>
The gene PIK3R1, encoding the p85alpha regulatory subunit of the phosphatidylinositol 3-kinase, is a logical candidate gene for involvement in the development of Type 2 diabetes owing to its role in insulin signal transduction. An intronic variant, SNP42, was associated with increased disease risk under two genetic models (OR 1.41, p = 0.0090 for the allele 2 dominant and OR1.34, p = 0.0088 for the additive model; see Table 2). In the QT study, SNP42 was significantly associated with increased BMI and showed a borderline significance with increased fasting insulin (measure of insulin resistance) under a dominant model for allele 2 (see Table S2). Obesity is a major risk factor for insulin resistance, and the observed increase in BMI coupled with increased insulin resistance in carriers of allele G at SNP42 suggests that variation at this gene may be increasing Type 2 diabetes risk through impaired insulin action. Other association studies at this locus have focussed on investigating the Met326Ile variant in disease predisposition, with mostly negative results (T. Hansen et al. 1997, 2001; Kawanishi et al. 1997). One study did describe an association with disease status and with QTs underlying Type 2 diabetes (Baier et al. 1998). However, functional data for this polymorphism have suggested that the Ile326 variant may have only minor impact on signalling events (Baynes et al. 2000; Almind et al. 2002). Our data suggest that variation in this gene is a risk factor for the development of Type 2 diabetes, although further detailed studies will be required to elucidate the precise functional variants and mechanisms that lead to increased disease risk.
###end p 32
###begin p 33
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOS1</italic>
###xml 15 41 15 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">son of sevenless homolog 1</italic>
###xml 45 55 45 55 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Drosophila</named-content>
###xml 525 526 525 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 542 549 542 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t002">Table 2</xref>
###xml 668 672 668 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOS1</italic>
###xml 45 55 <span type="species:ncbi:7227">Drosophila</span>
The gene SOS1 (son of sevenless homolog 1 in Drosophila) encodes a guanine nucleotide exchange factor that functions in the transduction of signals that control cell growth and differentiation. We analysed two SNPs for association with disease status, a nonsynonymous SNP (N1011S) and an intronic variant (SNP8). While the nonsynonymous S1011 variant, which was very rare (minor allele, 0.003), did not associate with disease status, the intronic SNP was highly significantly associated with decreased disease risk (OR 0.58, p = 0.0032) (see Table 2), despite not showing any effects in the QT study. To our knowledge, this is the first investigation into the role of SOS1 in Type 2 diabetes risk. The data presented here suggest that further investigation into the potential role of common variants at this gene and diabetes risk is warranted.
###end p 33
###begin title 34
Other Genes
###end title 34
###begin p 35
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARGC1</italic>
###xml 196 218 196 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Puigserver1">Puigserver et al. 1998</xref>
###xml 247 261 247 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Wu1">Wu et al. 1999</xref>
###xml 291 307 288 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Vega1">Vega et al. 2000</xref>
###xml 350 368 347 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Herzig1">Herzig et al. 2001</xref>
###xml 370 386 367 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Yoon1">Yoon et al. 2001</xref>
###xml 424 443 421 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Michael1">Michael et al. 2001</xref>
###xml 446 453 443 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARGC1</italic>
###xml 527 534 524 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t002">Table 2</xref>
###xml 626 634 623 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="st002">Table S2</xref>
###xml 879 893 876 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Ek1">Ek et al. 2001</xref>
###xml 915 931 912 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Hara1">Hara et al. 2002</xref>
###xml 933 955 930 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Lacquemant1">Lacquemant et al. 2002</xref>
###xml 957 975 954 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Muller1">Muller et al. 2003</xref>
###xml 1040 1056 1037 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Hara1">Hara et al. 2002</xref>
###xml 1085 1107 1082 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Esterbauer1">Esterbauer et al. 2002</xref>
###xml 1167 1185 1164 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Muller1">Muller et al. 2003</xref>
###xml 1353 1354 1350 1351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1370 1377 1367 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t002">Table 2</xref>
###xml 1518 1540 1515 1537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Esterbauer1">Esterbauer et al. 2002</xref>
###xml 1658 1658 1655 1655 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 1078 1083 <span type="species:ncbi:9606">women</span>
PPARGC1 (LocusLink ID 10891) encodes a transcriptional coactivator of nuclear receptors with a critical role in regulating multiple aspects of energy metabolism, including adaptive thermogenesis (Puigserver et al. 1998), mitochondrial biogenesis (Wu et al. 1999), fatty acid beta-oxidation (Vega et al. 2000), the control of hepatic gluconeogenesis (Herzig et al. 2001; Yoon et al. 2001), and the control of glucose uptake (Michael et al. 2001). PPARGC1 SNP30 (Thr528Thr), which was associated with decreased disease risk (see Table 2), was rather surprisingly associated with decreased insulin secretion in the QT study (see Table S2). In this locus, Thr528Thr has not been previously associated with diabetes, and our data most likely reflect stochastic variation at this site. The Gly482Ser has in some studies been shown to be associated with increased Type 2 diabetes risk (Ek et al. 2001), but not in others (Hara et al. 2002; Lacquemant et al. 2002; Muller et al. 2003), and has additionally been associated with insulin resistance (Hara et al. 2002), obesity indices in women (Esterbauer et al. 2002), and mean insulin secretory response and lipid oxidation (Muller et al. 2003). In our study, this allele was not associated with increased diabetes risk, but rather was associated with a lower risk of diabetes under a recessive model (OR 0.67, p = 0.0295) (see Table 2). The opposing results for this polymorphism and the fact that the amino acid change Gly482Ser is unlikely to be a major functional change (Esterbauer et al. 2002) may indicate that the contributing functional polymorphism may be an unidentified variant in LD with the Gly482Ser.
###end p 35
###begin p 36
###xml 87 90 87 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PYY</italic>
###xml 271 272 271 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 317 318 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 366 373 366 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t002">Table 2</xref>
###xml 517 520 517 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PYY</italic>
###xml 562 582 562 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Bertrand1">Bertrand et al. 1992</xref>
###xml 584 609 584 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Nieuwenhuizen1">Nieuwenhuizen et al. 1994</xref>
###xml 759 763 759 763 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3&#8211;36</sub>
###xml 889 894 889 894 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3&#8211;36 </sub>
###xml 934 955 934 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Batterham1">Batterham et al. 2002</xref>
###xml 1082 1085 1082 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PYY</italic>
###xml 1162 1165 1162 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PYY</italic>
###xml 847 851 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
###xml 897 903 <span type="species:ncbi:9606">humans</span>
Amongst the remaining genes tested, of particular interest are the results observed in PYY (encoding polypeptide YY; LocusLink ID 5697). An intronic variant, IVS3+68, showed a significant association with increased Type 2 diabetes risk under two genetic models (OR 1.47, p = 0.0240 in the allele 2 dominant; OR 1.47, p = 0.0157 in the additive effect allele 2) (see Table 2), but no evidence of association with underlying traits was observed in the QT study. Early functional studies suggested an inhibitory role of PYY in glucose-stimulated insulin secretion (Bertrand et al. 1992; Nieuwenhuizen et al. 1994), which led us to evaluate the potential role of variants at this gene in Type 2 diabetes predisposition. Recent data have shown that the peptide PYY3-36 encoded by this gene inhibits food intake and reduces weight gain when injected in rats, while physiological infusions of PYY3-36 in humans decreased food intake by 33% (Batterham et al. 2002). Although our data do not show an association between the intronic variant SNP122 with BMI, they suggest a putative role for PYY in Type 2 diabetes predisposition. As we only tested a noncoding variant in PYY, it is possible that the association is due to other contributing variants within the gene and that a link between those and BMI is still plausible.
###end p 36
###begin p 37
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC9</italic>
###xml 39 39 39 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LIPC</italic>
In the genes ABCC9 (LocusLink ID 10060) and LIPC (LocusLink ID 3990), single SNPs of modest significance were associated with disease status in the case control and therefore are not discussed further here.
###end p 37
###begin title 38
Examination of Other Previously Reported Associations
###end title 38
###begin p 39
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 220 241 220 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Altshuler1">Altshuler et al. 2000</xref>
###xml 406 413 406 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t002">Table 2</xref>
###xml 471 472 471 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 588 589 588 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 660 682 660 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Altshuler1">Altshuler et al. (2000</xref>
###xml 1129 1145 1129 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Luan1">Luan et al. 2001</xref>
We were unable to confirm some associations observed in other studies. The PPARG Pro12Ala Pro allele has previously been shown to confer susceptibility to Type 2 diabetes, with the Ala allele providing a decreased risk (Altshuler et al. 2000). Our results for this polymorphism show the same direction and magnitude of effect for Ala/Ala versus Ala/Pro and Pro/Pro genotypes (OR 0.54; derived from data in Table 2), but the association was not statistically significant (p = 0.2269). The lower limit of the 95% CI for the protective effect of the Ala allele (OR 1.08, 95% CI [0.82,1.42], p = 0.583) is still consistent with the results of the meta-analysis by Altshuler et al. (2000). Our study was not sufficiently powered to detect the small effects expected for the predisposing Pro allele. The study only had 25.4% power to detect an OR of 1.25 for the Pro allele that occurred in 89.4% of our control population. It is also possible that the Pro12Ala variant does not affect diabetes susceptibility in this population, because of the dependence of the allele effect on environmental factors such as dietary fat composition (Luan et al. 2001).
###end p 39
###begin p 40
###xml 7 12 7 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENPP1</italic>
###xml 32 32 32 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 37 37 37 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PC-1</italic>
###xml 169 183 169 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Gu1">Gu et al. 2000</xref>
###xml 185 206 185 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Rasmussen1">Rasmussen et al. 2000</xref>
###xml 208 226 208 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Hegele2">Hegele et al. 2001</xref>
###xml 261 280 261 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Pizzuti1">Pizzuti et al. 1999</xref>
###xml 282 296 282 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Gu1">Gu et al. 2000</xref>
###xml 298 319 298 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Rasmussen1">Rasmussen et al. 2000</xref>
###xml 437 438 437 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 494 495 494 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 552 553 552 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 556 559 556 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0.7</italic>
###xml 616 616 616 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 616 623 616 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t002">Table 2</xref>
###xml 771 772 771 772 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 878 885 878 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPP1R3A</italic>
###xml 1089 1096 1089 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPP1R3A</italic>
###xml 1167 1188 1167 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Hansen1">L. Hansen et al. 1995</xref>
###xml 1196 1214 1196 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Hegele1">Hegele et al. 1998</xref>
###xml 1216 1231 1216 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Xia1">Xia et al. 1998</xref>
###xml 1485 1486 1485 1486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1517 1535 1517 1535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Savage1">Savage et al. 2002</xref>
In the ENPP1 (LocusLink ID 5167) gene (commonly known as PC-1) the K121Q polymorphism has variably been found to be both associated with increased Type 2 diabetes risk (Gu et al. 2000; Rasmussen et al. 2000; Hegele et al. 2001) and with insulin resistance QTs (Pizzuti et al. 1999; Gu et al. 2000; Rasmussen et al. 2000). In our study we did not find evidence for association between the K121Q polymorphism and Type 2 diabetes (OR 1.10, p = 0.5277 for the dominant model for allele 2; OR 1.07, p = 0.6290 for the additive effect for allele 2; OR 0.86, p = 0.7496 for a recessive model for allele 2; data derived fromTable 2). Analysis of this allele in our QT study showed that QQ individuals have higher mean BMI levels compared to carriers of the K121 allele (28.3 kg/m2 [26.4, 30.2] versus 26.1 [25.6, 26.7] in KQ subjects, 26.3 [25.9, 26.6] in KK subjects; data not shown). PPP1R3A (protein phosphatase 1 regulatory subunit 3; LocusLink ID 5506), which encodes the muscle-specific regulatory subunit of PP1, has been investigated as a potential diabetogene. Evidence for a role of the PPP1R3A D905Y polymorphism in Type 2 diabetes risk has also been conflicting (L. Hansen et al. 1995, 2000; Hegele et al. 1998; Xia et al. 1998). While in this study we did not find an association between the D905Y variant and disease risk, we have previously described an association between a rare frameshift and premature stop variant with Type 2 diabetes risk under a dominant model (OR 5.03, p = 0.0110) in this population (Savage et al. 2002).
###end p 40
###begin title 41
Concluding Remarks
###end title 41
###begin p 42
This study, which to our knowledge is the largest of its kind yet reported in Type 2 diabetes, has provided evidence for the existence of variants in certain key candidate genes that influence the risk of Type 2 diabetes and, in some cases, has afforded clues as to the pathophysiological mechanism whereby those effects on disease risk might be mediated. By its very nature, any study of candidate genes, however large, is restricted in scope, and it is likely that other variants (namely in regulatory regions, which we did not cover) in the genes that we have considered, as well as ones that we have not, may exist and have effects equal to or greater than those we have demonstrated. In addition, this study is not intended to be an 'exclusion study,' as many issues that relate to coverage of any given gene, environmental risk factors, and power in our populations do not allow us to definitively assert that negative findings correspond to genes that truly do not play a role in Type 2 diabetes predisposition.
###end p 42
###begin p 43
###xml 292 300 292 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0000020-g004">Figure 4</xref>
###xml 948 975 948 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Benjamini1">Benjamini and Hochberg 1995</xref>
###xml 1521 1545 1521 1545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Lander1">Lander and Kruglyak 1995</xref>
The power of our study to detect small effects in uncommon variants was low. Evidence from many recent studies now suggests that in Type 2 diabetes the effects are likely in the range of OR 1.15-1.5. It is clear that much larger studies than that reported here are required for such effects (Figure 4), in particular when adjusting to a lower Type 1 error rate of 0.01% to compensate for multiple testing. The significance of the associations we report have been described without adjustment for the number of tests undertaken, and thus the group of positive associations is likely to contain a proportion that is falsely positive. There is no consensus about the ideal method for adjusting the probability of an observation occurring by chance for multiple testing. The simple Bonferroni correction would constitute overadjustment because the 152 genetic markers in this study are not independent. In addition, in the false-discovery rate method (Benjamini and Hochberg 1995), it is assumed that all N tests are carried out simultaneously, which may not correspond to reality if groups genotype one set of SNPs, as in this study, but then report results for additional SNPs at a later date. It is not clear whether the number of tests N should reflect the number to date or the number one might potentially undertake by continuing working through projects like these. An alternative Bayesian approach leading to a 'genome-wide' significance level for association, such as has been done for whole-genome linkage studies (Lander and Kruglyak 1995), might be preferable. However, this also runs into difficulties. In studies that are not based on fine-mapping of linkage intervals, but rather on candidate genes selected on the basis of data from other studies, including previous reports of association, it is unclear what level of prior probability of association should be used. As a result of this uncertainty about the appropriate method of correction for multiple testing, our preferred strategy is to report the number of tests done and to encourage readers to interpret the significance tests in that light, acknowledging that the results will require replication in other cohorts.
###end p 43
###begin p 44
###xml 832 837 832 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
Although we have not undertaken a formal replication of the case-control study, we have used a complimentary QT population to examine the association of the variants studied with continuously distributed measures of glucose tolerance, insulin secretion, and insulin action. This provides different information to a replication case-control study, as it may identify pathophysiological mechanisms by which the association with diabetes arises. We are cautious about putting forward particular variants as established 'diabetogenes' and enthusiastically invite researchers to examine these candidate variants in their own particular populations. Indeed, as the genetic architecture of Type 2 diabetes may vary between populations, it is critical that such variants are examined in multiple diverse ethnic groups. As with the Pro12Ala PPARG example, it is likely that meta-analysis of several studies will be required to narrow the CIs around the point estimates of association seen in any single study. This will be especially important when the association is weak, as it is for Pro12Ala, because few individual case-control studies, including the one reported here, are currently powered to detect very small increases in risk. It is, however, important that such meta-analyses include all studies of variants examined, rather than only those that are individually published, to avoid publication bias.
###end p 44
###begin p 45
###xml 1538 1543 <span type="species:ncbi:9606">human</span>
The associations we describe are highly biologically plausible and in many of the genes are supported by associations with multiple SNPs at the same locus. These include genes affecting both insulin secretion and insulin action. Given the importance of both insulin resistance and defective beta-cell function to the pathogenesis of Type 2 diabetes, it is intriguing that we have found a disproportionate representation of genes affecting pancreatic beta-cell function among those that were found to be associated with diabetes risk. This contrasts with the impact of known environmental factors and their correlates (e.g., high-fat diet, lower physical activity, obesity, and central fat distribution), all of which are thought to have their major influence on diabetes risk through impairment of insulin action. While it would be premature to put forward any definitive model for the causation of Type 2 diabetes, it is tempting to speculate that the 'insulin resistance' component of the disease may have a substantial environmental influence modulated by polygenic effects, some of which may relate to molecules identified in this and other studies. On the other hand, the ability of the pancreatic beta-cell to continue to secrete sufficient insulin to maintain life-long normoglycaemia may be more profoundly influenced by genetic factors, some of which are reported herein. It will be critical to examine the functional consequences of such variants, a task that will be particularly challenging when it comes to genes influencing human beta-cell function, as it is entirely possible that this disproportionate representation of beta-cell genes may be a reflection of our success in choosing diabetes genes in each of the candidate genes in the major groupings.
###end p 45
###begin p 46
###xml 100 100 100 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
The success of the approach presented here, although necessarily limited in scope, suggests that thesystematic examination of panels of biological candidate genes in large, well-characterised populations may usefully complement positional approaches to the identification of allelic variants conferring susceptibility to complex polygenic disease. The detection of multiple small gene effects accentuates the need for larger populations in order to reliably identify the types of effects (OR 1.15-1.5) we now expect for complex diseases.
###end p 46
###begin title 47
Materials and Methods
###end title 47
###begin title 48

###end title 48
###begin title 49
Methods for SNP discovery and SNP selection for genotyping.
###end title 49
###begin p 50
###xml 85 103 85 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Thorpe1">Thorpe et al. 1999</xref>
###xml 527 546 527 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Barroso1">Barroso et al. 1999</xref>
###xml 364 369 <span type="species:ncbi:9606">human</span>
SNP discovery was performed by a high-fSSCP-based analysis, as previously described (Thorpe et al. 1999). Genomic structure was determined for all genes, and primers were designed to span the exons and splice junctions. To detect common variants, genes were screened against one or more of a variety of different DNA panels, which included a 47-member multiethnic human diversity panel (comprised of 17 Europid, seven Hispanic, 13 East Asian, and ten African-American subjects), our 129-member severe insulin-resistant cohort (Barroso et al. 1999), a panel of 47 European-American samples, a panel of 47 African-American samples, and in some cases a panel of 94 samples (half European and half Asian Indian). Some genes had only partially screened coding sequence and splice junctions at the time of SNP selection for genotyping. In addition, we had access to an internal database of in silico SNPs that had been validated against 100 samples. Choice of polymorphisms for further testing in association studies was not constrained by the type of variant (e.g., nonsynonymous, silent, noncoding), although higher priority was given to variants with a likely effect on protein structure and function. Polymorphisms with a minor allele frequency greater than or equal to 5% were selected for further testing in population-based studies. In some instances, polymorphisms of lower allele frequency were genotyped to examine whether lower frequency variants with high penetrance might account for some cases of polygenic disease. Polymorphisms of lower frequency were also genotyped when, at the time of selection for genotyping, no other variants of known frequency were identified in the gene to test.
###end p 50
###begin title 51
Populations for SNP genotyping.
###end title 51
###begin p 52
###xml 44 63 44 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Poulton1">Poulton et al. 2002</xref>
###xml 65 84 65 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Halsall1">Halsall et al. 2003</xref>
###xml 867 868 867 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
###xml 1020 1045 1020 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Standing1">Standing and Taylor (1992</xref>
###xml 1246 1253 1246 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0000020-t005">Table 5</xref>
###xml 1255 1255 1255 1255 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 203 206 <span type="species:ncbi:9606">men</span>
###xml 211 216 <span type="species:ncbi:9606">women</span>
The Cambridgeshire Case-Control Population (Poulton et al. 2002; Halsall et al. 2003) consists of a collection of 517 Type 2 diabetics and 517 matched controls. The cases were a random sample of Europid men and women with Type 2 diabetes, aged 47-75 years, from a population-based diabetes register in a geographically defined region in Cambridgeshire, United Kingdom. The presence of Type 2 diabetes in these subjects was defined as onset of diabetes after the age of 30 years without use of insulin therapy in the first year after diagnosis. The control subjects were individually age-, gender-, and geographical location-matched to each of the cases. Controls were not matched by BMI to cases. Potential controls that had HbA1c levels greater than 6% were excluded, as this group may contain a higher proportion of individuals with previously undiagnosed diabetics. HbA1c was assayed using high performance liquid chromatography on a BioRad Diamat 33 (Hercules, California, United States), according to the method of Standing and Taylor (1992). The coefficient of variation (CV) was 3.6% at the lower end of the range (mean = 4.94%) and 3.0% at the upper end (mean = 9.76%). Further details on the characteristics of the subjects are shown in Table 5.
###end p 52
###begin p 53
###xml 3 3 3 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 216 235 216 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Wareham1">Wareham et al. 1999</xref>
###xml 568 585 568 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Kunst1">Kunst et al. 1983</xref>
###xml 660 663 660 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 697 714 697 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Sobey1">Sobey et al. 1989</xref>
###xml 716 733 716 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Alpha1">Alpha et al. 1992</xref>
###xml 338 350 <span type="species:ncbi:9606">participants</span>
The QT study population is a collection of 1,100 samples collected for the Ely Study, a prospective population-based cohort study of the aetiology and pathogenesis of Type 2 diabetes and related metabolic disorders (Wareham et al. 1999). Height was measured using rigid stadiometer, and weight was measured on Seca-calibrated scales with participants in light clothing. BMI was estimated as weight (kg) divided by height (m) squared. Plasma glucose was measured in the routine National Health Service Laboratory at Addenbrooke's Hospital, using the hexokinase method (Kunst et al. 1983). Plasma insulin was measured by two-site immunometric assays with either 125I or alkaline phosphatase labels (Sobey et al. 1989; Alpha et al. 1992). Cross-reactivity with intact proinsulin was less than 0.2% and CVs were less than 7%.
###end p 53
###begin title 54
Methods for genotyping.
###end title 54
###begin p 55
###xml 618 634 599 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Chen1">Chen et al. 1999</xref>
###xml 1468 1468 1449 1449 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
Genotyping was performed using an adaptation of the fluorescence polarisation template-directed incorporation (FP-TDI) method described by Chen et al.(1999). In short, PEP-amplified DNA samples were PCR-amplified in 8 mul reactions with primers flanking the variant site; unincorporated dNTP and remaining unused primer were degraded by exonuclease I and shrimp alkaline phosphatase at 37degreesC for 45 min before the enzymes were heat-inactivated at 95degreesC for 15 min. At the end of the reaction, the samples were held at 4degreesC. Single base primer extension reactions were performed as previously described (Chen et al. 1999), and allele detection was performed by measuring fluorescence polarisation on an LJL Analyst fluorescent reader (Molecular Devices, Sunnyvale, California, United States). The PEP protocol was specifically developed and tested to ensure that allele bias was not introduced during the amplification process. A minimum of 12% internal replicate samples within each population (case control and QT) were included in all genotyping tests to assess genotyping accuracy. Only assays that provided 100% concordance between replicates were analysed for association. The genotyping pass rate was greater than 90% once a working assay had been established. There was an 85% success rate for an SNP to be converted into a working assay at the first attempt, with a number of failed assays recovered by designing an assay to the reverse strand.
###end p 55
###begin title 56
Statistical analysis.
###end title 56
###begin p 57
###xml 263 264 261 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 339 340 337 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 338 340 336 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
###xml 358 371 356 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Lewontin1">Lewontin 1964</xref>
All analyses used SAS 8.02 (SAS Institute, Cary, North Carolina, United States) or Stata 7.0 (Stata Corporation, College Station, Texas, United States) statistical programs, unless otherwise stated. Agreement with Hardy-Weinberg equilibrium was tested using a chi2 'goodness-of-fit' test. The disequilibrium coefficient for the controls (r2) was calculated (Lewontin 1964).
###end p 57
###begin p 58
###xml 685 686 685 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 793 794 793 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1378 1401 1378 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Chiano1">Chiano and Clayton 1998</xref>
###xml 1403 1414 1403 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Mander1">Mander 2001</xref>
###xml 1550 1561 1550 1561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Mander1">Mander 2001</xref>
###xml 1724 1735 1724 1735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Mander1">Mander 2001</xref>
For the case-control study, tests for association with disease status under dominant, additive, and recessive models were undertaken using univariate logistic regression analysis. Dominance was defined in terms of allele 2 effects; in the dominant allele 2 model, homozygous subjects for allele 1 were compared with carriers of allele 2; in the recessive allele 2 model, carriers of allele 1 were compared with homozygous subjects for allele 2. In some cases, a large number of polymorphisms within a gene were typed. To reduce complexity, a subset of markers within a gene associated with diabetes status was identified using backward logistic regression. Any polymorphism that had a p value greater than 0.1 was removed from the model. The genotypes were assumed as having additive effects. p values for the additive effect are for the test for a linear trend across the genotypes, which were coded as 0 = 11, 1 = 12, 2 = 22. Where the subset consisted of more than one polymorphism within a gene, haplotype analysis was performed. To avoid possible errors due to either genotyping or the estimation process, only haplotypes that had a frequency greater than 5% were considered for further analysis. Haplotype frequencies were estimated using maximum-likelihood methods. A log-linear model embedded with the expectation-maximization algorithm was fitted to a frequency table (Chiano and Clayton 1998; Mander 2001). Differences in haplotype distributions between the diabetic and nondiabetic groups were examined using a likelihood-ratio statistic (Mander 2001). To obtain separate ORs for each haplotype, the most common haplotype was used as the reference category. CIs were obtained using a profile-likelihood approach (Mander 2001).
###end p 58
###begin p 59
###xml 1507 1517 1507 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-Huber1">Huber 1967</xref>
###xml 1519 1529 1519 1529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-White1">White 1980</xref>
###xml 1531 1535 1531 1535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-White2">1982</xref>
For the QT study, the distributions of fasting plasma glucose, 2-h plasma glucose, fasting plasma insulin, and insulin increment were skewed and were thus normalised by logarithmic transformation. Baseline and follow-up measurements of BMI, fasting and 2-h plasma glucose, fasting plasma insulin, and 30-min insulin increment during an oral glucose tolerance test were collected. Where two measures were available, the mean was used. Otherwise, a single measure (either baseline or follow-up) was used for further analysis. The subset of SNPs identified in the case-control study was used. In separate dominant, additive, and recessive models, adjusting for age and sex, genotype differences in these measurements were modelled using the General Linear Model procedure in the statistical package SAS. For each individual, a list of possible haplotypes and their probabilities was obtained using Snphap software (). Haplotypes with a frequency greater than 5% were the same as those reconstructed in the case-control study. Only haplotypes that had a frequency greater than 5% and individuals that had at least one marker typed were considered for analysis. As currently haplotype analysis software cannot handle repeated measurements, the average of two measurements was used for further analysis. Associations of haplotypes (adjusted for age and sex) with the QTs were determined by cluster-weighted regression analysis, thereby taking into account nonindependent multiple observations from an individual (Huber 1967; White 1980, 1982). QT means and their 95% CI were estimated for each haplotype.
###end p 59
###begin title 60
Supporting Information
###end title 60
###begin title 61
Genotype Counts and Frequencies for All SNPs Genotyped in This Study
###end title 61
###begin p 62
(79 KB XLS).
###end p 62
###begin p 63
Click here for additional data file.
###end p 63
###begin title 64
Single SNP Associations with QTs
###end title 64
###begin p 65
(174 KB DOC).
###end p 65
###begin p 66
Click here for additional data file.
###end p 66
###begin title 67
Accession Numbers
###end title 67
###begin p 68
The LocusLink accession numbers discussed in this paper are 3170, 3172, 3630, 3643, 3767, 3990, 5167, 5295, 5468, 5506, 5697, 6514, 6654, 6833, 6927, 6928, 10060, 10891, and 11132.
###end p 68
###begin p 69
NJW is a Wellcome Trust Senior Clinical Fellow. The Ely Study is supported by the Medical Research Council. SO is supported by the Wellcome Trust and the Medical Research Council. DC is supported by the Wellcome Trust and the Juvenile Diabetes Research Foundation. This study drew upon the combined efforts of many individuals at Incyte Genomics Cambridge, to whom we extend our grateful appreciation. We also thank Suzannah Bumpstead, Bill Bottomley, and Stephan Collins for technical assistance. We are grateful to anonymous reviewers for helpful comments and suggestions.
###end p 69
###begin title 70
References
###end title 70
###begin article-title 71
Characterization of the Met326Ile variant of phosphatidylinositol 3-kinase p85alpha
###end article-title 71
###begin article-title 72
###xml 57 62 <span type="species:ncbi:9606">human</span>
Sensitive amplified immunoenzymometric assays (IEMA) for human insulin and intact proinsulin
###end article-title 72
###begin article-title 73
The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
###end article-title 73
###begin article-title 74
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human hepatocyte nuclear factor-4 (hHNF-4) gene maps to 20q12-q13.1 between PLCG1 and D20S17
###end article-title 74
###begin article-title 75
###xml 201 206 <span type="species:ncbi:9606">women</span>
Variant in the regulatory subunit of phosphatidylinositol 3-kinase (p85alpha): Preliminary evidence indicates a potential role of this variant in the acute insulin response and type 2 diabetes in Pima women
###end article-title 75
###begin article-title 76
A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance
###end article-title 76
###begin article-title 77
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT2</italic>
Polymorphisms at the GLUT2 (beta-cell/liver) glucose transporter gene and noninsulin-dependent diabetes mellitus (NIDDM): Analysis in affected pedigree members
###end article-title 77
###begin article-title 78
###xml 31 36 <span type="species:ncbi:9606">human</span>
Dominant negative mutations in human PPARgammaassociated with severe insulin resistance, diabetes mellitus and hypertension
###end article-title 78
###begin article-title 79
Gut hormone PYY(3-36) physiologically inhibits food intake
###end article-title 79
###begin article-title 80
###xml 20 25 <span type="species:ncbi:9606">human</span>
Natural variants of human p85 alpha phosphoinositide 3-kinase in severe insulin resistance: A novel variant with impaired insulin-stimulated lipid kinase activity
###end article-title 80
###begin article-title 81
Controlling the false discovery rate: A practical and powerful approach to multiple testing
###end article-title 81
###begin article-title 82
###xml 71 75 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Evidence for a direct inhibitory effect of PYY on insulin secretion in rats
###end article-title 82
###begin article-title 83
###xml 30 35 <span type="species:ncbi:9606">human</span>
Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy
###end article-title 83
###begin article-title 84
Fluorescence polarization in homogeneous nucleic acid analysis
###end article-title 84
###begin article-title 85
Fine genetic mapping using haplotype analysis and the missing data problem
###end article-title 85
###begin article-title 86
Challenges in identifying genetic variation affecting susceptibility to type 2 diabetes: Examples from studies of the calpain-10 gene
###end article-title 86
###begin article-title 87
Calpain 10 gene polymorphisms are related, not to type 2 diabetes, but to increased serum cholesterol in Japanese
###end article-title 87
###begin article-title 88
PS power and sample size program
###end article-title 88
###begin article-title 89
Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus
###end article-title 89
###begin article-title 90
Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians
###end article-title 90
###begin article-title 91
###xml 124 129 <span type="species:ncbi:9606">women</span>
Peroxisome proliferator-activated receptor-gamma coactivator-1 gene locus: Associations with obesity indices in middle-aged women
###end article-title 91
###begin article-title 92
Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom
###end article-title 92
###begin article-title 93
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
###end article-title 93
###begin article-title 94
###xml 9 15 9 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
SNP43 of CAPN10 and the risk of type 2 diabetes in African-Americans: The Atherosclerosis Risk in Communities Study
###end article-title 94
###begin article-title 95
Type 2 diabetes: Evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs
###end article-title 95
###begin article-title 96
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SUR1</italic>
###xml 115 121 115 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kir6.2</italic>
Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53)
###end article-title 96
###begin article-title 97
###xml 119 125 119 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 137 142 137 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
###xml 161 167 161 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
Large-scale association studies of variants in genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with Type 2 diabetes
###end article-title 97
###begin article-title 98
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PC-1</italic>
###xml 24 29 <span type="species:ncbi:9606">human</span>
Association between the human glycoprotein PC-1 gene and elevated glucose and insulin levels in a paired-sibling analysis
###end article-title 98
###begin article-title 99
Typical type 2 diabetes mellitus and HFE gene mutations: A population-based case-control study
###end article-title 99
###begin article-title 100
###xml 74 75 74 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 90 100 90 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KIR6.2/BIR</italic>
Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): A meta-analysis suggests a role in the polygenic basis of Type II diabetes mellitus in Caucasians
###end article-title 100
###begin article-title 101
A widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phosphatase-1 is associated with insulin resistance and hypersecretion of insulin
###end article-title 101
###begin article-title 102
The Val985Met insulin-receptor variant in the Danish Caucasian population: Lack of associations with noninsulin-dependent diabetes mellitus or insulin resistance
###end article-title 102
###begin article-title 103
###xml 90 96 90 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPP1R3</italic>
Polymorphism in the glycogen-associated regulatory subunit of type 1 protein phosphatase (PPP1R3) gene and insulin sensitivity
###end article-title 103
###begin article-title 104
Identification of a common amino acid polymorphism in the p85alpha regulatory subunit of phosphatidylinositol 3-kinase: Effects on glucose disappearance constant, glucose effectiveness, and the insulin sensitivity index
###end article-title 104
###begin article-title 105
Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene
###end article-title 105
###begin article-title 106
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SUR1</italic>
Genetic variability of the SUR1 promoter in relation to beta-cell function and Type II diabetes mellitus
###end article-title 106
###begin article-title 107
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PGC-1</italic>
A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to Type II diabetes
###end article-title 107
###begin article-title 108
Association of the insulin-receptor variant Met-985 with hyperglycemia and noninsulin-dependent diabetes mellitus in The Netherlands: A population-based study
###end article-title 108
###begin article-title 109
Variants in the sulphonylurea receptor gene: Association of the exon 16-3t variant with Type II diabetes mellitus in Dutch Caucasians
###end article-title 109
###begin article-title 110
Prevalence of variants in candidate genes for type 2 diabetes mellitus in The Netherlands: The Rotterdam study and the Hoorn study
###end article-title 110
###begin article-title 111
Variation in the AU(AT)-rich element within the 3'-untranslated region of PPP1R3 is associated with variation in plasma glucose in aboriginal Canadians
###end article-title 111
###begin article-title 112
Absence of association of type 2 diabetes with CAPN10 and PC-1 polymorphisms in Oji-Cree
###end article-title 112
###begin article-title 113
CREB regulates hepatic gluconeogenesis through the coactivator PGC-1
###end article-title 113
###begin article-title 114
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF2</italic>
Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY
###end article-title 114
###begin article-title 115
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
###end article-title 115
###begin article-title 116
Analysis of parent-offspring trios provides evidence for linkage and association between the insulin gene and type 2 diabetes mediated exclusively through paternally transmitted class III variable number tandem repeat alleles
###end article-title 116
###begin article-title 117
###xml 48 51 48 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SUR</italic>
Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians
###end article-title 117
###begin article-title 118
###xml 51 56 <span type="species:ncbi:9606">human</span>
New susceptibility locus for NIDDM is localized to human chromosome 20q
###end article-title 118
###begin article-title 119
###xml 135 143 <span type="species:ncbi:9606">patients</span>
Prevalence of a polymorphism of the phosphatidylinositol 3-kinase p85 alpha regulatory subunit (codon 326 Met-->Ile) in Japanese NIDDM patients
###end article-title 119
###begin article-title 120
Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections
###end article-title 120
###begin article-title 121
Further evidence for a susceptibility locus for type 2 diabetes on chromosome 20q13.1-q13.2
###end article-title 121
###begin article-title 122
No association between the G482S polymorphism of the proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene and Type II diabetes in French Caucasias
###end article-title 122
###begin article-title 123
Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
###end article-title 123
###begin article-title 124
The interaction of selection and linkage. I. General considerations: Heterotic models
###end article-title 124
###begin article-title 125
###xml 29 34 <span type="species:ncbi:9606">human</span>
Genetic polymorphisms at the human liver/islet glucose transporter (GLUT2) gene locus in Caucasian and West Indian subjects with type 2 (noninsulin-dependent) diabetes mellitus
###end article-title 125
###begin article-title 126
###xml 90 96 90 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kir6.2</italic>
An E23K single nucleotide polymorphism in the islet ATP-sensitive potassium channel gene (Kir6.2) contributes as much to the risk of Type II diabetes in Caucasians as the PPAR Pro12Ala variant
###end article-title 126
###begin article-title 127
Evidence for gene-nutrient interaction at the PPARgamma locus
###end article-title 127
###begin article-title 128
Exclusion of the hepatocyte nuclear factor 4alpha as a candidate gene for late-onset NIDDM linked with chromosome 20q
###end article-title 128
###begin article-title 129
###xml 13 20 13 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NEUROD1</italic>
Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus
###end article-title 129
###begin article-title 130
Haplotype analysis in population-based association studies
###end article-title 130
###begin article-title 131
Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1
###end article-title 131
###begin article-title 132
Studies of the genetic variability of the coding region of the hepatocyte nuclear factor-4alpha in Caucasians with maturity onset NIDDM
###end article-title 132
###begin article-title 133
###xml 72 80 <span type="species:ncbi:9606">patients</span>
Studies of genetic variability of the glucose transporter 2 promoter in patients with type 2 diabetes mellitus
###end article-title 133
###begin article-title 134
A Gly482Ser missense mutation in the peroxisome proliferator-activated receptor gamma coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians
###end article-title 134
###begin article-title 135
The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of Type 2 diabetes
###end article-title 135
###begin article-title 136
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
Mechanisms underlying the insulinostatic effect of peptide YY in mouse pancreatic islets
###end article-title 136
###begin article-title 137
###xml 57 65 <span type="species:ncbi:9606">patients</span>
Detection of mutations in insulin-receptor gene in NIDDM patients by analysis of single-stranded conformation polymorphisms
###end article-title 137
###begin article-title 138
Insulin receptor and insulin-responsive glucose transporter (GLUT4) mutations and polymorphisms in a Welsh Type 2 (noninsulin-dependent) diabetic population
###end article-title 138
###begin article-title 139
A genome scan for type 2 diabetes susceptibility loci in a genetically isolated population
###end article-title 139
###begin article-title 140
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PC-1</italic>
###xml 30 35 <span type="species:ncbi:9606">human</span>
A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance
###end article-title 140
###begin article-title 141
Type 2 diabetes is associated with a common mitochondrial variant: Evidence from a population-based case-control study
###end article-title 141
###begin article-title 142
###xml 75 83 <span type="species:ncbi:9606">patients</span>
Analysis of the HNF4 alpha gene in Caucasian type II diabetic nephropathic patients
###end article-title 142
###begin article-title 143
A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis
###end article-title 143
###begin article-title 144
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PC-1</italic>
###xml 25 30 <span type="species:ncbi:9606">human</span>
The K121Q variant of the human PC-1 gene is not associated with insulin resistance or type 2 diabetes among Danish Caucasians
###end article-title 144
###begin article-title 145
###xml 54 59 <span type="species:ncbi:9606">human</span>
Digenic inheritance of severe insulin resistance in a human pedigree
###end article-title 145
###begin article-title 146
Nucleotide sensitivity of pancreatic ATP-sensitive potassium channels and type 2 diabetes
###end article-title 146
###begin article-title 147
K(IR)6.2 polymorphism predisposes to type 2 diabetes by inducing overactivity of pancreatic beta-cell ATP-sensitive K(+) channels
###end article-title 147
###begin article-title 148
Genotype/phenotype relationships in HNF-4alpha/MODY1: Haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels
###end article-title 148
###begin article-title 149
###xml 61 66 <span type="species:ncbi:9606">human</span>
Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins
###end article-title 149
###begin article-title 150
Glycated haemoglobin: An assessment of high capacity liquid chromatographic and immunoassay methods
###end article-title 150
###begin article-title 151
The maturity-onset diabetes of the young (MODY1) transcription factor HNF4alpha regulates expression of genes required for glucose transport and metabolism
###end article-title 151
###begin article-title 152
Early-onset type-II diabetes mellitus (MODY4) linked to IPF1
###end article-title 152
###begin article-title 153
###xml 94 102 <span type="species:ncbi:9606">patients</span>
Variability of the pancreatic islet beta cell/liver (GLUT2) glucose transporter gene in NIDDM patients
###end article-title 153
###begin article-title 154
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RING3</italic>
Detection of polymorphism in the RING3 gene by high-throughput fluorescent SSCP analysis
###end article-title 154
###begin article-title 155
Type 2 diabetes and three calpain-10 gene polymorphisms in Samoans: No evidence of association
###end article-title 155
###begin article-title 156
The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes
###end article-title 156
###begin article-title 157
Nonsense mutation in the glucokinase gene causes early-onset noninsulin-dependent diabetes mellitus
###end article-title 157
###begin article-title 158
Fasting proinsulin concentrations predict the development of type 2 diabetes
###end article-title 158
###begin article-title 159
The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
###end article-title 159
###begin article-title 160
Heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity
###end article-title 160
###begin article-title 161
Maximum likelihood estimation of misspecified models
###end article-title 161
###begin article-title 162
Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1
###end article-title 162
###begin article-title 163
###xml 20 26 20 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPP1R3</italic>
A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes
###end article-title 163
###begin article-title 164
###xml 96 101 92 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MODY1</italic>
Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1)
###end article-title 164
###begin article-title 165
###xml 96 101 92 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MODY3</italic>
Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3)
###end article-title 165
###begin article-title 166
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
###end article-title 166
###begin article-title 167
Type 2 (noninsulin-dependent) diabetes: An epidemiological overview
###end article-title 167
###begin article-title 168
A susceptibility locus for early-onset noninsulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene
###end article-title 168
###begin title 169
Abbreviations
###end title 169
###begin p 170
ATP-binding cassette
###end p 170
###begin p 171
body mass index
###end p 171
###begin p 172
confidence interval
###end p 172
###begin p 173
coefficient of variation
###end p 173
###begin p 174
fluorescent single-stranded conformation polymorphism
###end p 174
###begin p 175
glycated haemoglobin
###end p 175
###begin p 176
fasting insulin
###end p 176
###begin p 177
intervening sequence
###end p 177
###begin p 178
linkage disequilibrium
###end p 178
###begin p 179
maturity-onset diabetes of the young
###end p 179
###begin p 180
odds ratio
###end p 180
###begin p 181
fasting plasma glucose levels
###end p 181
###begin p 182
persistent hyperinsulinaemia hypoglycaemia of infancy
###end p 182
###begin p 183
peroxisome proliferator-activated receptor gamma
###end p 183
###begin p 184
protein phosphatase 1
###end p 184
###begin p 185
quantitative trait
###end p 185
###begin p 186
single nucleotide polymorphism
###end p 186
###begin p 187
variable number tandem repeat.
###end p 187
###begin title 188
Figures and Tables
###end title 188
###begin title 189
Study Design
###end title 189
###begin p 190
Candidate genes were selected based on known or putative function. A de novo polymorphism discovery step was undertaken to identify novel variants for association studies. We selected 152 SNPs and tested them in a case-control study and a QT study. Association analysis with Type 2 diabetes was done for SNPs and haplotypes under multiple genetic models. Only SNPs and haplotypes associated with disease were evaluated for association with five diabetes-related QTs under the same model in the QT study.
###end p 190
###begin title 191
Power Calculations
###end title 191
###begin p 192
###xml 317 340 317 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-DuPont1">DuPont and Plummer 1997</xref>
Power of the current Cambridgeshire Case-Control Study to detect associations with risk allele of varying frequencies and with a Type 1 error rate of 5%. Abbreviations: p0, frequency of the predisposing allele; chr, number of chromosomes. Graphs were plotted with the PS power and sample-size program (available at ; DuPont and Plummer 1997).
###end p 192
###begin title 193
Genes with Haplotypes Associated with Type 2 Diabetes
###end title 193
###begin p 194
###xml 296 297 296 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 295 297 295 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
###xml 338 350 338 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8&#8211;KCNJ11</italic>
###xml 356 361 356 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 367 371 367 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSR</italic>
Genomic organization with exons (black boxes or vertical lines) and with genotyped SNPs and SNPs utilised in the haplotype reconstructions (in blue boxes) is shown. The most common haplotypes with population prevalence greater than 5% in the control population are shown, and the measure of LD (r2) is shown for a subset of the SNPs. (A) ABCC8-KCNJ11. (B) HNF4A. (C) INSR.
###end p 194
###begin title 195
Size of Case-Control Study Required to Detect Small Risk Effects
###end title 195
###begin p 196
###xml 373 396 373 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0000020-DuPont1">DuPont and Plummer 1997</xref>
The number is shown of the case chromosomes (assuming an equal number of control chromosomes) required to attain 80% power to detect associations with the OR varying between 1.0 and 1.5 and with a Type 1 error rate of 0.01%. Abbreviations: p0, frequency of the predisposing allele; chr, number of chromosomes. Graphs were plotted with the PS power and sample-size program (DuPont and Plummer 1997).
###end p 196
###begin title 197
Genes with SNPs Genotyped in This Study
###end title 197
###begin p 198
Candidate genes, identified by official HUGO Gene Nomenclature Committee symbols, are grouped by known or putative biological function, with the number of genotyped polymorphisms per gene shown
###end p 198
###begin title 199
Continued
###end title 199
###begin title 200
Genes with Variants Significantly Associated with Type 2 Diabetes Status
###end title 200
###begin p 201
###xml 49 50 49 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 88 89 88 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
SNP identifiers (SNPID), OR, significance level (p value), and genetic model are shown. p values for the additive effect are for the test for a linear trend across the genotypes, which were coded as 0 = 11, 1 = 12, 2 = 22. Allele 2 dominant refers to a combination of 12 + 22 and allele 2 recessive refers to combination of 11 + 12
###end p 201
###begin title 202
###xml 15 27 15 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8&#8211;KCNJ11</italic>
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 35 35 35 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INSR</italic>
###xml 77 77 77 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
Association of ABCC8-KCNJ11, HNF4A, and INSR Haplotypes with Diabetes and QTs
###end title 202
###begin p 203
###xml 202 203 202 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 407 419 407 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">italics bold</italic>
###xml 407 419 407 419 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>italics bold</italic></bold>
###xml 442 442 442 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 442 442 442 442 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic/></bold>
###xml 454 454 454 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 454 454 454 454 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic/></bold>
###xml 454 462 454 462 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">red bold</bold>
###xml 462 463 462 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
###xml 462 463 462 463 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>.</italic></bold>
For case control, OR and 95% CI of haplotypes are shown. For QT, means and 95% CI of haplotypes are shown. Means were adjusted for age and sex, but not for BMI. Abbreviations: BMI, body mass index (kg/m2); PG0, fasting plasma glucose (mmol/l); 2hPG, 2-h plasma glucose (mmol/l); INS0, fasting insulin (pmol/l); Ins inc, 30-min insulin increment (pmol/mmol). Associations significant at 0.10 and below are initalics bold, with association 0.05 or below inred bold.
###end p 203
###begin title 204
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
Association of KCNJ11 and ABCC8 Variants with Type 2 Diabetes Status Adjusted for E23K Genotype
###end title 204
###begin p 205
###xml 49 50 49 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 88 89 88 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
SNP identifiers (SNPID), OR, significance level (p value), and genetic model are shown. p Values for the additive effect are for the test for a linear trend across the genotypes, which were coded as 0 = 11, 1 = 12, 2 = 22. Allele 2 dominant refers to a combination of 12 + 22 and the allele 2 recessive refers to combination of 11 + 12
###end p 205
###begin title 206
Study Subjects in the Cambridgeshire Case-Control Study
###end title 206
###begin p 207
Data are means and standard error is in parentheses
###end p 207
###begin p 208
###xml 0 22 0 22 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflicts of Interest.</bold>
Conflicts of Interest. Portions of the research were supported by Incyte Corporation (formerly Incyte Genomics). This collaboration provided access to certain technologies and scientific expertise for basic research in the genetics of diabetes in return for possible shared intellectual property. The work described here is not subject to any patent filings or intellectual property protection and restrictions from free use of the information. IB and AJS were employees of Incyte at the time the research took place.
###end p 208
###begin p 209
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author Contributions.</bold>
Author Contributions. IB, AJS, SO, and NW conceived and designed the experiments. IB, AJS, and NW performed the experiments or the fieldwork in the studies contributing data. IB, JL, RPSM, A-HH, PWF, RWJ, and NW analysed the data. DC contributed analysis tools and advice. All authors wrote the paper.
###end p 209
###begin p 210
Academic Editor: Philippe Froguel, Centre National de la Recherche Scientifique-Institut de Biologie de Lille.
###end p 210
###begin p 211
currency Present Address: The Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
###end p 211

